LIMA1 and metastatic neoplasm: Thus, the greatest advance of our study is demonstrating the clear prognostic role for LIMA1 in clinically relevant scenario where a clinician has to decide whether to attempt for curative intent surgery knowing that about half of those patients will develop later a metastatic disease, or whether to combine surgery with adjuvant therapy causing significant side effects that could have been avoided.